You are here

Home » Content

Koroner arter hastalığının değerlendirimesinde adenozin-stres kardiyak MR perfüzyon incelemesinin rolü

Adenosine stress cardiac magnetic resonance imaging method in detection of coronary artery disease

Journal Name:

  • Abant Tıp Dergisi

Publication Year:

  • 2013

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Coronary artery disease (CAD) is one of the main causes of morbidity and mortality. The evaluation of myocardial perfusion is important for excluding CAD. In the presence of CAD, it is crucial in determining the extent, severity, and haemodynamic importance of the lesions and deciding for appropriate revascularization strategies. Stress cardiac magnetic resonance imaging does not emit ionising radiation, has high spatial and temporal resolution, is able to evaluate subendocardial perfusion, and is a non-invasive modality; therefore it is the preferred method for myocardial perfusion evaluation.
Bookmark/Search this post with
Abstract (Original Language): 
Koroner arter hastalığı mortalite ve morbitenin ana nedenlerinden biridir. Koroner arter hastalığının dışlanmasında ya da varsa koroner arter lezyonlarının yaygınlığının, ciddiyetinin, hemodinamik öneminin belirlenmesinde ve buna bağlı olarak revaskülarizasyon stratejilerine kılavuzluk etmede miyokardiyal perfüzyonun değerlendirmesi önem taşımaktadır. Stres kardiyak MR perfüzyon görüntüleme, iyonizan radyasyon içermemesi, yüksek temporal ve uzaysal çözünürlüğe sahip olması, subendokardiyal perfüzyonun değerlendirilmesini mümkün kılması ve noninvazif bir modalite olması sebebiyle miyokardiyal perfüzyonun değerlendirmesinde tercih edilmektedir.
FULL TEXT (PDF): 
PDF icon arastirmax-koroner-arter-hastaliginin-degerlendirimesinde-adenozin-stres-kardiyak-mr-perfuzyon-incelemesinin-rolu.pdf
  • 3
265
273
  • Turkish

REFERENCES

References: 

1. Barkhausen J, Hunold P, Jochims M, Debatin JF. Imaging of myocardial perfusion with magnetic resonance Journal of Magnetic Resonance Imaging 2004;19:750-757.
2. Duerinckx AJ, Kumar NG. One-stop MR evaluates function and perfusion. CVT Diagnostic Imaging 2000; November:1-7.
3. Nagel E, Al-Saadi N, Fleck E. Cardiovascular magnetic resonance: myocardial perfusion. Herz 2000; 4:409-416.
4. Prasad SK, Lyne J, Chai P, Gatehouse P. Role of cardiac magnetic resonance in assessment of myocardial perfusion. Eur Radiol 2005; 15 (Suppl 2):B42-47.
5. Gerber BL, Raman SV, Nayak, Epstein FH, Ferreria P, Axel L, Kraitchman DL. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. Journal of Cardiovascular Magnetic Resonance 2008,10:18
6. Kim H.W, Klem I, Kim R. J. Detection of Myocardial İschemia by Stres Perfusion Cardiovascular Magnetic Resonance. Cardiology Clinics 2007;25:57-70.
7. Wright J, Bogaert J. The ESC Textbook of Cardiovascular İmaging. Springer-Verlag London Limited / CMR: Basic Principles. 2010;Chapter 6:111-120
8. Hamon M, Fau G, Née G, Ehtisham J, Morello R, HamonM. Meta-analysis of the diagnostic performanceof stres perfusion cardiovascular magnetic resonance for detection of coronary artery disease. Journal of Cardiovascular Magnetic Resonance 2010;12:29.
9. Jayaweera AR, Wei K, Coggins M, Bin JP, Goodman C, Kaul S. Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. Am J Physiol 1999,277(6 Pt 2):H2363-2372.
10. Raza JA, Reeves WC, Movahed A. Pharmacological stress agents for evaluation of ischemic heart disease. International Journal of Cardiology 2001;81:157-167.
11. Kayaalp O. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. 9. baskı. Hacettepe TAŞ. Ankara, 2000;602-603.
12. Burgstahler C, Kunze M, Gawaz MP, Rasche V, Wöhrle J, Hombach V, Merkle N: Adenosine stress first pass perfusion for the detection of coronary artery disease in patients with aortic stenosis: a feasibility study. Int J Cardiovasc Imaging 2008,24:195-200.
13. Greenwood JP, Younger JF, Ridgway JP, Sivananthan MU, Ball SG, Plein S. Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart 2007;93:1363-1368.
14. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and İnterventions. J Am Coll Cardiol 1999;33:1756-1824.
15. Pilz G, Bernhardt P, Klos M, Ali E, Wild M, Höfing B. Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potentialgatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol 2006;95:531-538.
16. Merkle N, Wöhrle J, Grebe O, Nusser T, Kunze M, Kestler HA, Kochs M, Hombach V. Assessment of myocardial perfusion for detection of coronary artery stenoses by steady-state, free-precession magnetic resonance first-pass imaging. Heart 2007,93:1381-1385.
17. Plein S, Greewood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004; 44:2173-2181.
18. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, Cawley P, Parker M, Elliott M, Judd RM, Kim RJ. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006; 47:1630-1638.
19. Klein C, Gebker R, Kokocinski T, Dreysse S, Schnackenburg B, Fleck E, Nagel E: Combined magnetic resonance coronary artery imaging, myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease. J Cardiovasc Magn Reson 2008;10:45.
20. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, Fleck E. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003;108:432-437.
21. Cheng AS, Pegg TJ, Karamitsos TD, Searle N, Jerosch-Herold M, Choudhury RP, Banning AP, Neubauer S, Robson MD, Selvanayagam JB. Cardiovascular magnetic resonace perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1.5-tesla. J Am Coll Cardiol 2007;49:2440-2449.
22. Meyer C, Strach K, Thomas D, Litt H, Nähle CP, Tiemann K, Schwenger U, Schild HH, Sommer T. High-resolution myocardial stress perfusion at 3 T in patients with suspected coronary artery disease. Eur Radiol 2008;18:226-233.
23. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977;31:42-48.
24. Klem I, Greulich S, Heitner JF, Kim H, Vogelsberg H, Kispert EM, Ambati SR, Bruch C, Parker M, Judd RM, Kim RJ, Sechtem U. Value of cardiovascular magnetic resonance stres perfusion testing for the detection of coronary artery disease in women. J Am Coll Cardiol Img 2008; 1:436-45.
25. Doğan MS. Koroner arter hastalığında miyokardiyal iskeminin kardiyak MR perfüzyon tetkiki ile değerlendirilmesi: Katater ve BT anjiyografi bulguları ile karşılaştırma. Tıpta Uzmanlık Tezi. Dokuz Eylül Üniversitesi Tıp Fakültesi. 2011

Thank you for copying data from http://www.arastirmax.com